Najjam Asghar
2021
In 2021, Najjam Asghar earned a total compensation of $1.9M as Former Senior Vice President and Chief Financial Officer at Sorrento Therapeutics, a 7% decrease compared to previous year.
Compensation breakdown
| Option Awards | $832,650 |
|---|---|
| Salary | $450,000 |
| Stock Awards | $579,995 |
| Other | $37,342 |
| Total | $1,899,987 |
Asghar received $832.7K in option awards, accounting for 44% of the total pay in 2021.
Asghar also received $450K in salary, $580K in stock awards and $37.3K in other compensation.
Rankings
In 2021, Najjam Asghar's compensation ranked 6,234th out of 12,415 executives tracked by ExecPay. In other words, Asghar earned more than 49.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,234 out of 12,415 | 50th |
Division Manufacturing | 2,642 out of 5,505 | 52nd |
Major group Chemicals And Allied Products | 1,157 out of 2,375 | 51st |
Industry group Drugs | 1,029 out of 2,096 | 51st |
Industry Biological Products, Except Diagnostic Substances | 247 out of 449 | 45th |
Pay ratio
| Najjam Asghar's Pay | $1,899,987 |
|---|---|
| Median Employee's Pay | $130,192 |
| Pay Ratio | 15to 1 |
In 2021, the annual total compensation of Najjam Asghar was $1,899,987.
The annual total compensation of the median employee at Sorrento Therapeutics was $130,192.
The ratio of Najjam Asghar's pay to the pay of median employee was therefore 15 to one.
Source: SEC filing on November 1, 2022.
Asghar's colleagues
We found one more compensation record of an executive who worked with Najjam Asghar at Sorrento Therapeutics in 2021.
2021
Henry Ji
Sorrento Therapeutics